Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 1,2-DAG(34:1) | cPLA2i | 1.0 | BCD110605C28 | 42.9 | pmol/sample |
| - | 1,2-DAG(34:1) | cPLA2i | 1.0 | BCD110605C30 | 17.7 | pmol/sample |
| - | 1,2-DAG(34:1) | cPLA2i | 1.0 | BCD110605C29 | 9.67 | pmol/sample |
| - | 1,2-DAG(34:1) | cPLA2i | 20.0 | BCD110605C64 | 93.9 | pmol/sample |
| - | 1,2-DAG(34:1) | cPLA2i | 20.0 | BCD110605C66 | 26.7 | pmol/sample |
| - | 1,2-DAG(34:1) | cPLA2i | 20.0 | BCD110605C65 | 12.4 | pmol/sample |
| - | 1,2-DAG(34:1) | PLDi | 1.0 | BCD110605C16 | 33.8 | pmol/sample |
| - | 1,2-DAG(34:1) | PLDi | 1.0 | BCD110605C17 | 8.3 | pmol/sample |
| - | 1,2-DAG(34:1) | PLDi | 1.0 | BCD110605C18 | 7.04 | pmol/sample |
| - | 1,2-DAG(34:1) | PLDi | 20.0 | BCD110605C54 | 19.5 | pmol/sample |
| - | 1,2-DAG(34:1) | PLDi | 20.0 | BCD110605C52 | - | pmol/sample |
| - | 1,2-DAG(34:1) | PLDi | 20.0 | BCD110605C53 | 4.09 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+cPLA2i | 1.0 | BCD110605C32 | 10.1 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+cPLA2i | 1.0 | BCD110605C31 | 33.3 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+cPLA2i | 1.0 | BCD110605C33 | 18.5 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+cPLA2i | 20.0 | BCD110605C68 | 22.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+cPLA2i | 20.0 | BCD110605C69 | 25.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+cPLA2i | 20.0 | BCD110605C67 | 55.8 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+PLDi | 1.0 | BCD110605C19 | 25.6 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+PLDi | 1.0 | BCD110605C20 | 6.51 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+PLDi | 1.0 | BCD110605C21 | 10.5 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+PLDi | 20.0 | BCD110605C56 | 9.63 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+PLDi | 20.0 | BCD110605C57 | 17.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+PLDi | 20.0 | BCD110605C55 | 52.8 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C37 | 114 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C38 | 19.5 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C39 | 16.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C74 | 17 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C75 | 27.5 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C73 | 59.3 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+PLDi | 1.0 | BCD110605C25 | 97.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+PLDi | 1.0 | BCD110605C27 | 0.767 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+PLDi | 1.0 | BCD110605C26 | 8.98 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+PLDi | 20.0 | BCD110605C61 | 59.3 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+PLDi | 20.0 | BCD110605C62 | 13.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO+ATP+PLDi | 20.0 | BCD110605C63 | 10.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO + ATP | 1.0 | BCD110605C15 | 11.3 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO + ATP | 1.0 | BCD110605C14 | 13.8 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO + ATP | 1.0 | BCD110605C13 | 58.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO + ATP | 20.0 | BCD110605C49 | 45.7 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO + ATP | 20.0 | BCD110605C50 | 12.3 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO + ATP | 20.0 | BCD110605C51 | 23.7 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO | 1.0 | BCD110605C08 | 9.93 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO | 1.0 | BCD110605C07 | 71 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO | 1.0 | BCD110605C09 | 10.7 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO | 20.0 | BCD110605C45 | 21.9 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO | 20.0 | BCD110605C44 | 20.4 | pmol/sample |
| - | 1,2-DAG(34:1) | KDO | 20.0 | BCD110605C43 | 89.5 | pmol/sample |
| - | 1,2-DAG(34:1) | C | 0.0 | BCD110605C03 | 15.6 | pmol/sample |
| - | 1,2-DAG(34:1) | C | 0.0 | BCD110605C01 | 55.5 | pmol/sample |